Contraception
Volume 80, Issue 6 , Pages 527-532, December 2009

Continuation rates and reasons for removal among Implanon® users accessing two family planning clinics in Queensland, Australia☆

  • Caroline Harvey

      Affiliations

    • Family Planning Queensland, Queensland 4006, Australia
    • Corresponding Author InformationCorresponding author. Tel.: +61 7 3250 0219.
    • ,
  • Charrlotte Seib

      Affiliations

    • School of Nursing, Queensland University of Technology, Queensland 4059, Australia
    • ,
  • Jayne Lucke

      Affiliations

    • School of Population Health, The University of Queensland, Queensland 4072, Australia

Received 1 May 2009; accepted 27 May 2009. published online 13 July 2009.

Abstract 

Background

This study examined demographic profile, continuation rates and reasons for removal among Implanon® users accessing two family planning clinics in Queensland, Australia.

Study Design

A retrospective chart audit of 976 women who attended for implant insertion over a 3-year period between May 2001 and May 2004.

Results

Continuation rates showed that at 6 months after insertion, 94% of women continued, 74% continued at 1 year and 50% continued at 2 years. Metropolitan women were more likely than rural women to discontinue use because of dissatisfaction with bleeding patterns. Cox regression analysis showed that those attending the regional clinic experienced significantly shorter time to removal.

Conclusions

Implanon® continuation rates and reasons for removal differ between clinics in metropolitan and rural locations. A cooling-off period did not affect the likelihood of continuation with Implanon®. Preinsertion counselling should emphasize potential changes in bleeding patterns.

Keywords: Implanon®, Clinical audit, Contraception, Etonogestrel implant, Discontinuation

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

☆ This clinical audit was funded by Organon (now Schering Plough) and Family Planning Queensland. Organon was not involved in the interpretation or reporting of the findings of the study. FPQ has received honoraria from Organon for contraception training sessions and Advisory Board attendance provided by Caroline Harvey. Organon provided travel support to Caroline Harvey for attendance at international contraception conferences. Charrlotte Seib and Jayne Lucke hold honorary positions as directors on the Board of Family Planning Queensland.

PII: S0010-7824(09)00300-X

doi:10.1016/j.contraception.2009.05.132

Contraception
Volume 80, Issue 6 , Pages 527-532, December 2009

Article Tools

* Image Usage & Resolution